menu
    • menu

    Company profile for Acura Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acura Pharmaceuticals, Inc. is an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. We have discovered and developed three proprietary platform technologies which can be used to develop multiple products. Our LIMITX™ Technology is intended to minimize the risks and side effects associated with overdose by retar...
    Acura Pharmaceuticals, Inc. is an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. We have discovered and developed three proprietary platform technologies which can be used to develop multiple products. Our LIMITX™ Technology is intended to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acura PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    616 N. North Court, Suite 120 Palatine, Illinois 60067
    Telephone
    Telephone
    (847) 705-7709
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://acurapharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acura Pharmaceuticals and AD Pharma Amend License to LIMITx LTX-03
    Acura Pharmaceuticals and AD Pharma Amend License to LIMITx LTX-03

    01 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/01/2394022/10047/en/Acura-Pharmaceuticals-and-AD-Pharma-Amend-License-to-LIMITx-LTX-03.html

    GLOBENEWSWIRE
    01 Mar 2022
    Share Share
    Acura Pharmaceuticals Provides Development Update on LTX-03
    Acura Pharmaceuticals Provides Development Update on LTX-03

    14 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/14/2384235/10047/en/Acura-Pharmaceuticals-Provides-Development-Update-on-LTX-03.html

    GLOBENEWSWIRE
    14 Feb 2022
    Share Share
    Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
    Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results

    16 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/16/2281550/10047/en/Acura-Pharmaceuticals-Announces-Second-Quarter-2021-Financial-Results.html

    GLOBENEWSWIRE
    16 Aug 2021
    Share Share
    Acura Pharmaceuticals and AD Pharma Amend License to LIMITxâ„¢ LTX-03
    Acura Pharmaceuticals and AD Pharma Amend License to LIMITxâ„¢ LTX-03

    26 Jul 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/26/2268955/10047/en/Acura-Pharmaceuticals-and-AD-Pharma-Amend-License-to-LIMITx-LTX-03.html

    GLOBENEWSWIRE
    26 Jul 2021
    Share Share
    Acura Pharmaceuticals Provides Development Update on LTX-03
    Acura Pharmaceuticals Provides Development Update on LTX-03

    07 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/07/2242538/10047/en/Acura-Pharmaceuticals-Provides-Development-Update-on-LTX-03.html

    GLOBENEWSWIRE
    07 Jun 2021
    Share Share
    Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
    Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

    28 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/10/28/2116311/0/en/Acura-Pharmaceuticals-and-AD-Pharma-Amend-License-to-LIMITx-LTX-03.html

    GLOBENEWSWIRE
    28 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search